Featured White Papers
Technology Industry
Industry: Email Alert RSS FeedVenture capital watch
BT Catalyst, Jan-Feb, 2004
One venture capital deal worth $2.43 million closed in October.
* BioMarck Pharmaceuticals Ltd., Raleigh, $2.43 million
From 46 private angel investors.
COPYRIGHT 2004 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning